glp-1 vs compounded semaglutide Compound Compounded Semaglutide (GLP-1) 3 Month
Description
95% CI, 0.89 to 1.42)
GLP-1 medications continue to be a major topic in the fitness and weight loss world
Eli Lilly offers Mounjaro and Zepbound, while Novo Nordisks portfolio includes Ozempic, Wegovy, and Saxenda.
These figures highlight how, even with broader coverage, patient behavior and systemic barriers continue to erode both demand and health outcomes in this rapidly evolving market
For some, the weight loss drug Ozempic is life-changing
What does this mean for their long-term health?
